# Research Proposal: Multi-Scale Geometric Learning for Pocket-Aware Molecule Optimization

## 1. Introduction

### Background

Drug discovery and development remains one of the most challenging and resource-intensive endeavors in modern science, with average development timelines exceeding 10 years and costs surpassing $2.6 billion per approved drug. A significant contributor to this inefficiency is the high attrition rate during lead optimization, where promising molecular candidates fail due to poor binding affinity, inadequate selectivity, or unfavorable pharmacokinetic properties when evaluated in the context of their target binding pockets. Traditional computational approaches have attempted to address these challenges through separate optimization pipelines—one focusing on molecular property enhancement and another on structure-based binding assessment—creating a fundamental disconnect that leads to suboptimal candidates.

Recent advances in geometric deep learning have demonstrated remarkable success in molecular representation learning, with SE(3)-equivariant neural networks capturing the rotational and translational symmetries inherent in 3D molecular structures. Simultaneously, diffusion-based generative models have emerged as powerful tools for molecular generation, offering controlled sampling and high-quality outputs. However, current methods exhibit critical limitations: they either treat ligand modification in isolation from pocket constraints (leading to molecules with improved intrinsic properties but poor binding characteristics) or focus solely on pocket-conditioned generation without systematic property optimization.

The literature reveals significant progress in addressing individual aspects of this challenge. MCGM demonstrates effective capture of long-range interactions through hierarchical clustering, while PAMol introduces hypergraph representations for pocket structure modeling. DiffBP and PoLiGenX showcase the potential of diffusion models for structure-based ligand generation. However, no existing framework seamlessly integrates multi-scale geometric learning with pocket-aware optimization while simultaneously addressing multiple drug-like property objectives.

### Research Objectives

This research proposes to develop **PocketOpt**, a unified multi-scale geometric learning framework for pocket-aware molecule optimization that addresses the following objectives:

1. Design a hierarchical geometric representation that captures molecular interactions at atomic, functional group, and pocket-ligand interface scales simultaneously
2. Develop a learnable geometric pocket field encoding electrostatic, hydrophobic, and steric constraints as continuous differentiable functions
3. Create a pocket-conditioned diffusion model for fragment-level molecular modification that respects geometric constraints
4. Integrate multi-objective optimization combining binding affinity, synthetic accessibility, and ADMET properties into a unified reward framework

### Significance

This research addresses a critical bottleneck in computational drug discovery by bridging the gap between molecular property optimization and structural compatibility assessment. Success in this endeavor could reduce late-stage drug candidate failures by 20-30%, potentially saving billions of dollars in development costs and accelerating the delivery of effective therapeutics to patients.

## 2. Methodology

### 2.1 Overview

PocketOpt consists of three interconnected modules: (1) a Multi-Scale Geometric Encoder (MSGE) that learns hierarchical representations of both ligands and binding pockets, (2) a Pocket Field Generator (PFG) that encodes pocket constraints as learnable geometric fields, and (3) a Pocket-Conditioned Diffusion Optimizer (PCDO) that iteratively modifies molecular fragments while respecting pocket constraints.

### 2.2 Multi-Scale Geometric Encoder (MSGE)

The MSGE operates at three distinct scales using SE(3)-equivariant message passing to ensure geometric consistency.

**Atomic Scale Representation**: Given a molecular graph $G = (V, E)$ with node features $\mathbf{h}_i^{(0)}$ and 3D coordinates $\mathbf{x}_i$, we compute equivariant atomic embeddings through:

$$\mathbf{m}_{ij} = \phi_m\left(\mathbf{h}_i^{(l)}, \mathbf{h}_j^{(l)}, \|\mathbf{x}_i - \mathbf{x}_j\|, e_{ij}\right)$$

$$\mathbf{h}_i^{(l+1)} = \phi_h\left(\mathbf{h}_i^{(l)}, \sum_{j \in \mathcal{N}(i)} \mathbf{m}_{ij}\right)$$

where $\phi_m$ and $\phi_h$ are learnable MLPs, and $e_{ij}$ represents edge features including bond type and distance embeddings.

**Functional Group Scale**: We employ a hierarchical clustering mechanism inspired by MCGM to identify functional groups. Atoms are clustered based on chemical similarity and spatial proximity:

$$\mathbf{c}_k = \text{Cluster}\left(\{\mathbf{h}_i^{(L)}, \mathbf{x}_i\}_{i \in S_k}\right)$$

where $S_k$ denotes the set of atoms in functional group $k$. The cluster representation aggregates atomic features through attention-weighted pooling:

$$\mathbf{g}_k = \sum_{i \in S_k} \alpha_{ik} \mathbf{h}_i^{(L)}, \quad \alpha_{ik} = \frac{\exp(\mathbf{w}^\top \mathbf{h}_i^{(L)})}{\sum_{j \in S_k} \exp(\mathbf{w}^\top \mathbf{h}_j^{(L)})}$$

**Pocket-Ligand Interface Scale**: For interface modeling, we construct a bipartite graph connecting ligand atoms to nearby pocket residues within a cutoff distance $r_c = 8$ Å. The interface representation employs cross-attention:

$$\mathbf{z}_i^{(\text{interface})} = \text{CrossAttn}(\mathbf{h}_i^{(\text{ligand})}, \{\mathbf{h}_j^{(\text{pocket})}\}_{j: \|\mathbf{x}_i - \mathbf{x}_j\| < r_c})$$

### 2.3 Pocket Field Generator (PFG)

The PFG encodes binding pocket constraints as continuous geometric fields, enabling differentiable assessment of ligand compatibility at any 3D position.

**Field Definition**: We define three complementary fields over the pocket volume:

1. **Electrostatic Field** $\Phi_E(\mathbf{r})$: Encodes charge distributions
$$\Phi_E(\mathbf{r}) = \sum_{j \in \text{pocket}} \frac{q_j}{\epsilon(\mathbf{r}) \|\mathbf{r} - \mathbf{x}_j\| + \delta}$$

2. **Hydrophobic Field** $\Phi_H(\mathbf{r})$: Captures hydrophobic preferences
$$\Phi_H(\mathbf{r}) = \sum_{j \in \text{pocket}} h_j \cdot \exp\left(-\frac{\|\mathbf{r} - \mathbf{x}_j\|^2}{2\sigma_h^2}\right)$$

3. **Steric Field** $\Phi_S(\mathbf{r})$: Represents excluded volume constraints
$$\Phi_S(\mathbf{r}) = \sum_{j \in \text{pocket}} \left(\frac{r_j^{\text{vdw}}}{\|\mathbf{r} - \mathbf{x}_j\|}\right)^{12}$$

These fields are made learnable by parameterizing $q_j$, $h_j$, $\epsilon(\mathbf{r})$, and $\sigma_h$ through neural networks conditioned on pocket residue embeddings:

$$\mathbf{f}(\mathbf{r}) = \text{MLP}\left(\Phi_E(\mathbf{r}), \Phi_H(\mathbf{r}), \Phi_S(\mathbf{r}), \mathbf{r}^{\text{rel}}\right)$$

where $\mathbf{r}^{\text{rel}}$ represents position relative to the pocket centroid.

### 2.4 Pocket-Conditioned Diffusion Optimizer (PCDO)

The PCDO employs a diffusion-based generative model to iteratively modify molecular fragments while conditioning on the pocket field.

**Forward Process**: Given a ligand molecule $\mathbf{M}_0$, we define the forward diffusion process:
$$q(\mathbf{M}_t | \mathbf{M}_{t-1}) = \mathcal{N}(\mathbf{M}_t; \sqrt{1-\beta_t}\mathbf{M}_{t-1}, \beta_t\mathbf{I})$$

where $\beta_t$ is the noise schedule and the process operates on both atomic coordinates and features.

**Reverse Process with Pocket Conditioning**: The reverse process learns to denoise while respecting pocket constraints:
$$p_\theta(\mathbf{M}_{t-1} | \mathbf{M}_t, \mathbf{f}) = \mathcal{N}(\mathbf{M}_{t-1}; \mu_\theta(\mathbf{M}_t, t, \mathbf{f}), \Sigma_\theta(\mathbf{M}_t, t, \mathbf{f}))$$

The denoising network $\mu_\theta$ incorporates pocket field information through cross-attention mechanisms:
$$\mu_\theta(\mathbf{M}_t, t, \mathbf{f}) = \text{EquivariantUNet}(\mathbf{M}_t, t) + \lambda \cdot \text{PocketGuidance}(\mathbf{M}_t, \mathbf{f})$$

**Fragment-Level Modification**: Rather than generating entire molecules, we identify modifiable fragments and apply localized diffusion:
1. Identify modification sites using attention scores from the interface representation
2. Mask selected fragments while preserving scaffold connectivity
3. Apply diffusion-based generation conditioned on both the pocket field and remaining molecular context

### 2.5 Multi-Objective Reward Integration

We define a composite reward function combining multiple objectives:

$$\mathcal{R}(\mathbf{M}, \mathbf{P}) = w_1 \cdot \mathcal{R}_{\text{affinity}}(\mathbf{M}, \mathbf{P}) + w_2 \cdot \mathcal{R}_{\text{SA}}(\mathbf{M}) + w_3 \cdot \mathcal{R}_{\text{ADMET}}(\mathbf{M})$$

where:
- $\mathcal{R}_{\text{affinity}}$ is predicted binding affinity from a pretrained scoring function
- $\mathcal{R}_{\text{SA}}$ is synthetic accessibility score
- $\mathcal{R}_{\text{ADMET}}$ combines absorption, distribution, metabolism, excretion, and toxicity predictions

The model is trained using a combination of denoising score matching and reward-weighted likelihood:
$$\mathcal{L} = \mathcal{L}_{\text{DSM}} + \gamma \cdot \mathbb{E}[\mathcal{R}(\mathbf{M}_0, \mathbf{P}) \cdot \log p_\theta(\mathbf{M}_0 | \mathbf{f})]$$

### 2.6 Experimental Design

**Datasets**: We utilize CrossDocked2020 (22.5M protein-ligand pairs), PDBbind v2020 (19,443 complexes with binding affinity data), and ZINC20 for pretraining molecular representations.

**Baselines**: Comparisons include DiffBP, PoLiGenX, Diffleop, GraphXForm, and traditional methods (AutoGrow4, REINVENT).

**Evaluation Metrics**:
1. **Binding Affinity**: Vina docking scores, MM-GBSA binding free energy
2. **Binding Affinity Retention**: Percentage of optimized molecules maintaining >80% of original binding affinity
3. **Property Improvement**: QED, SA score, predicted ADMET properties
4. **Geometric Validity**: Clash-free percentage, strain energy
5. **Diversity**: Tanimoto similarity distribution among generated molecules
6. **Success Rate**: Percentage meeting all criteria simultaneously

**Ablation Studies**: We systematically evaluate contributions of (1) multi-scale representation, (2) pocket field conditioning, (3) fragment-level vs. full-molecule generation, and (4) multi-objective reward integration.

## 3. Expected Outcomes & Impact

### Expected Outcomes

1. **Performance Improvements**: We anticipate PocketOpt will achieve 20-30% improvement in binding affinity retention compared to pocket-agnostic methods, with simultaneous maintenance or improvement of drug-like properties.

2. **Computational Efficiency**: The fragment-level modification approach should reduce generation time by 40-50% compared to full molecule generation while maintaining quality.

3. **Multi-Objective Balance**: We expect successful generation of molecules that simultaneously satisfy binding affinity (Vina score < -8 kcal/mol), synthetic accessibility (SA score < 4), and favorable ADMET profiles (>70% passing rate) at rates exceeding 60% of generated candidates.

4. **Benchmark Contributions**: Release of a curated benchmark dataset with pocket-ligand pairs annotated with comprehensive property profiles.

### Impact

**Scientific Impact**: This research advances the theoretical understanding of how geometric constraints can be effectively integrated into molecular generative models, providing a principled framework for pocket-aware optimization that can inspire future developments in structure-based drug design.

**Practical Impact**: By generating pocket-compatible candidates earlier in the optimization pipeline, PocketOpt could reduce lead optimization cycles from months to weeks, significantly accelerating drug discovery timelines. The framework's ability to simultaneously optimize multiple objectives addresses a critical need in pharmaceutical development.

**Broader Impact**: Faster and more efficient drug discovery directly translates to accelerated patient access to life-saving medications. The reduction in late-stage failures would also decrease the environmental and financial costs associated with drug development, making pharmaceutical research more sustainable.